![PDF) Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia | Augustin Ferrant and Marinus Kooy - Academia.edu PDF) Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia | Augustin Ferrant and Marinus Kooy - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/43212005/mini_magick20220706-28999-158d421.png?1657150843)
PDF) Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia | Augustin Ferrant and Marinus Kooy - Academia.edu
![PDF) Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real‐life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart PDF) Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real‐life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart](https://i1.rgstatic.net/publication/331911828_Arterial_occlusive_events_in_chronic_myeloid_leukemia_patients_treated_with_ponatinib_in_the_real-life_practice_are_predicted_by_the_Systematic_Coronary_Risk_Evaluation_SCORE_chart/links/5cf3352c4585153c3dab7141/largepreview.png)
PDF) Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real‐life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart
![Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study | Blood Cancer Journal Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-020-0333-2/MediaObjects/41408_2020_333_Fig1_HTML.png)
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study | Blood Cancer Journal
Ravendex on Twitter: "@cardano_daily @adax_pro @wmtoken @get_revuto @kicklaunchpad @CamelcoinThe @peepsule @Pavia_io @ArdanaProject Ravendex Testnet Coming On @Milkomeda_com Soon!" / Twitter
![Remote Sensing | Free Full-Text | Linear and Non-Linear Models for Remotely-Sensed Hyperspectral Image Visualization Remote Sensing | Free Full-Text | Linear and Non-Linear Models for Remotely-Sensed Hyperspectral Image Visualization](https://www.mdpi.com/remotesensing/remotesensing-12-02479/article_deploy/html/images/remotesensing-12-02479-g010.png)
Remote Sensing | Free Full-Text | Linear and Non-Linear Models for Remotely-Sensed Hyperspectral Image Visualization
Tornado in Italia - ⛈ Riprendiamo il radar cml, per vedere bene la piccola #supercella a sud di #Pavia in moto verso sud-est. Prudenza in zona. - Tornado in Italia - | Facebook
![FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells | Leukemia FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.leu.2404510/MediaObjects/41375_2007_Article_BF2404510_Fig2_HTML.jpg)
FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells | Leukemia
![Choice of Frontline Tyrosine-Kinase Inhibitor in Very Elderly Patients with Chronic Myeloid Leukemia: A “Campus CML” Study - ScienceDirect Choice of Frontline Tyrosine-Kinase Inhibitor in Very Elderly Patients with Chronic Myeloid Leukemia: A “Campus CML” Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497121055415-gr1.jpg)
Choice of Frontline Tyrosine-Kinase Inhibitor in Very Elderly Patients with Chronic Myeloid Leukemia: A “Campus CML” Study - ScienceDirect
![A Prospective Study in Ph+ Chronic Myeloid Leukemia (CML) Patients Showing That Interphase Fluorescence in Situ Hybridization (FISH) Is Effective as Conventional Cytogenetics for Definition of Cytogenetic Response. Correlation with Molecular Response ( A Prospective Study in Ph+ Chronic Myeloid Leukemia (CML) Patients Showing That Interphase Fluorescence in Situ Hybridization (FISH) Is Effective as Conventional Cytogenetics for Definition of Cytogenetic Response. Correlation with Molecular Response (](https://ars.els-cdn.com/content/image/1-s2.0-S0006497118462180-fx1.jpg)
A Prospective Study in Ph+ Chronic Myeloid Leukemia (CML) Patients Showing That Interphase Fluorescence in Situ Hybridization (FISH) Is Effective as Conventional Cytogenetics for Definition of Cytogenetic Response. Correlation with Molecular Response (
![Interferon Alfa-2a as Compared with Conventional Chemotherapy for the Treatment of Chronic Myeloid Leukemia | NEJM Interferon Alfa-2a as Compared with Conventional Chemotherapy for the Treatment of Chronic Myeloid Leukemia | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1994/nejm_1994.330.issue-12/nejm199403243301204/production/images/img_medium/nejm199403243301204_f1.jpeg)